| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1900084 | 重组抗EGFR人鼠嵌合单克隆抗体注射液 | Recombinant anti-EGFR human-mouse chimeric monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-07-31 | 浙江新维盛科生物技术有限公司 | Zhejiang Xinweishengke Biotechnology Co Ltd | In Review | 2019-07-29 | view |